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Abstract The solubility of acetaminophen in SuperCritical-Carbon Dioxide (SC-CO2) with and without
menthol as a cosolvent wasmeasured at various temperatures (313, 328 and 343) K, and within pressures
ranging from (10 to 25) MPa. It should be stated that the cosolvent, menthol, has chiral isomers with
differentmelting points. Therefore, the effects of bothmenthol (I) with a lowermelting point andmenthol
(II) with a higher melting point, as cosolvents on the solubility of acetaminophen in SC-CO2, were studied.
The experimental data collected in thisworkwere obtained using a static flow apparatus. The experiments
were replicated at least three times and the data reported are the average of the replicas. Finally, the
data reduction for the solubility of acetaminophen in SC-CO2 in the presence and in the absence of
menthol (I) and menthol (II), were correlated, using the semi-empirical equations proposed by Chrastil
andMendez-Santiago & Teja. The results obtained from these equations were in good agreement with the
experimental data.
© 2012 Sharif University of Technology. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
Acetaminophen (AC), N-acetyl-p-aminophenol, is a widely
used analgesic and antipyretic agent. It is used to treat con-
ditions such as headaches, muscle aches, arthritis, backaches,
toothaches, colds and fevers [1]. However, low solubility in wa-
ter makes it difficult to be highly bioavailable in the human
body. This is a limitation in pharmaceutical applications and,
therefore, a new form of delivery system is required for such
a drug. Various methods have been developed to modify the
bioavailability of drugs. Micronization is one of the most com-
monly used methods to control drug release. This method can
improve the drug therapeutic efficacy, in vitro and in vivo sta-
bility, bioavailability, targetability, and control the biodistribu-
tion [2–4].
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doi:10.1016/j.scient.2011.11.046In recent years, micronization techniques with supercritical
fluids have been used in the production of ultrafine particles
in a variety of industries, such as polymer, pharmaceutical,
cosmetics, coating and toiletry. Several supercritical fluid
processes were used to produce fine particles. The results
of such processes were extensively reported in the literature
[5–10].
The Rapid Expansion of Supercritical Solution (RESS) is a
process in which a supercritical fluid is used as a solvent.
For instance, a solid is dissolved in SC–CO2 in an extraction
chamber, and then it is expanded at ambient pressure through a
nozzle. It is a simple process that enables generation of solvent
free fine particles, without the presence of hazardous organic
solvents and drying processes [11–16]. The applicability of this
process is strongly dependent upon the solubility of the solid
component in the supercritical solvent, i.e. SC–CO2.
The equilibrium solubility is the most important thermo-
dynamic parameter that controls both extraction and precipi-
tation processes. The majority of pharmaceuticals are organic
polar compounds for which CO2 cannot be considered a good
solvent, due to its low polarity. Poor solubility leads to a lim-
ited use of supercritical CO2 as a solvent for commercial pro-
duction in the RESS process. To overcome this problem, various
evier B.V. Open access under CC BY-NC-ND license.
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Compound Formula CAS number MW Tm (K) Molecular structure
Acetaminophen C8H9NO2 103-90-2 151.16 443
Menthol (I) C10H20O 89-78-1 156.27 304.307
Menthol (II) C10H20O 2216-51-5 156.27 314.317Figure 1: Schematic diagram of static flow apparatus for solubility measurements.liquid cosolvents were introduced to enhance solubility in su-
percritical CO2. For example, Bristow et al. [17] used ethanol to
increase the solubility of AC in SC–CO2. Thakur and Gupta [18]
modified the RESS method and used menthol as a solid cosol-
vent to produce fine particles. Thismethodwas called the Rapid
Expansion of Supercritical Solution - Solid Cosolvent (RESS-SC).
According to them,menthol has proper properties, such as high
solubility in SC–CO2, low reactivity with drugs or CO2, low toxi-
city, sufficiently high vapour pressure, so that the cosolvent can
be removed by sublimation, and has less expense than other
solid cosolvents [19],whichmakesmenthol a suitable choice for
cosolvent.
The acetaminophen solubility data in the literature is very
limited; moreover, the effect of menthol as an enhancer of the
solubility of acetaminophen has not yet been reported.
In this study, the solubility of AC in pure supercritical
carbon dioxide, with and without menthol (I) and menthol
(II) as cosolvents, at various temperatures ranging from (313
to 343) K, and different pressures within the range of (10 to
25) MPa, was investigated.
2. Materials and methods
2.1. Materials
Carbon dioxide with the purity of 99.99% was purchased
from Farafan Gas Company, Tehran, Iran. Two menthol iso-
mers with different melting points, with at least 99% purity,werepurchased fromMerckCompany,Hohenbrunn, GmbH.Ac-
etaminophen, with the purity of 99.93%, was obtained from Jali-
nus Company, Tehran, Iran. It should be stated that all chemicals
were used as received, without any further purification.
Table 1 gives the physical properties for the chemicals
used in this study. As observed, two isomers of menthol have
different melting points and, in turn, depict different solvating
power.
2.2. Apparatus and procedure
A schematic diagram of the apparatus used in this study is
shown in Figure 1. This equipment was set up for solubility
measurement and RESS-SC study. Pressures in the range of (10
to 25) MPa and the temperatures in the range of (313 to 343) K
were investigated with this apparatus.
In order to keep the temperatures of the equilibrium cells
constant, a high accuracy temperature controlled air bath with
an uncertainty of ±0.3 K was used. The capacity of the equi-
librium cells placed in the air bath, vessels 5 and 6 in the
schematic diagram, were (200 and 300) cm3, respectively. The
cells were filled with acetaminophen and cosolvents at various
temperatures and pressures. The pressure of the cells wasmea-
sured with a digital pressure transducer with an uncertainty of
±0.1 MPa. The equilibrium cells were pressurized with liquid
CO2 using a reciprocating HPLC pump modified with a cooling
head. To measure the solubility of pure AC in SC–CO2, 1.5 g of
AC was weighed by an accurate balance (Mettler Toledo model
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SC–CO2 at T = 328 K.
P (MPa) 103 · y2a 103 · y2a
10.1 2.92 3.01
12 12.29 12.41
18.7 39.28 39.89
22.06 43.66 44.1
24.8 49.69 49.97
a McHugh M. and Paulaitis M.E.
AB265-S/FACT, with an uncertainty of ±0.01 mg). The AC was
introduced into each equilibrium cell. In order to measure the
solubility of AC in the presence of cosolvents, 2 g of AC, along
with 20 g of menthol, was charged into each equilibrium cell. It
is worth pointing out that glass granular beadswere introduced
into the equilibrium cells in association with the chemicals to
increase the contact surface area. Prior to conducting the exper-
iments, the air inside the cells was purged from the apparatus
using a CO2 injection. To make sure that the systems reached
the equilibrium condition, different samples were taken out
from the cells at different time steps, and the solubility of AC
in SC–CO2 was measured. The results confirmed that after 5 h,
the system can reach the equilibrium condition, and no change
in the solubility of AC in SC–CO2, with time, was observed. Hav-
ing reached the equilibrium condition, 0.901 cm3 of saturated
SC–CO2 was withdrawn from the equilibrium cells and intro-
duced into the sample loop. Finally, the sample loop was de-
pressurized into a collection vial containing ethanol. The loop
was washed with the same solvent and collected in the collec-
tion vial. The solubility of AC in SC–CO2 was determined by an
Agilent 8453-series Diode array UV–Visible spectrophotometer
(Agilent Technologies, Santa Clara, USA), with 1 nm resolution
and 190-1100 nm wavelength range. A 10 mm quartz cell was
used as the sample cell. The acetaminophen exhibits a UV ab-
sorbance peak in the presence of ethanol at 250 nm.
The solubility of menthol in SC–CO2 was determined by
gas chromatography instruments. A model 6890 N (Agilent
technologies, Santa Clara, USA) gas chromatograph, equipped
with flame ionization detectors and fitted with a HP-5 5%
Phenyl methyl siloxane (30m× 0.25mm× 0.25µm) capillary
column, was used. The injector temperature was 523 K, the
detector 523 K and the oven temperature was programmed at
a rate of 30 K/min from 323 K to 473 K. The flow rate of helium
was used at 40 ml/min.
In general, the uncertainty of the solubility measurements
was estimated to be about±10% for acetaminophen and±15%
for menthol.
3. Results and discussion
To check the accuracy of the experimental procedure,
the solubility of naphthalene at 328 K was measured as a
control and compared to the results obtained by McHugh and
Paulaitis [20]. Our data, however, are systematically slightly
higher than those reported by McHugh and Paulaitis. The data
presented in Table 2 verifies that our experimental procedure
is able to duplicate the solubility measurements of the flow
systems found in the literature.
After verifying that our procedures were able to accurately
measure solubilities, we proceededwithmeasuring the solubil-
ities of acetaminophen in carbon dioxide. Table 3 demonstrates
the experimental data for the solubility of pure AC in SC–CO2 at
various temperatures and pressures. As explained earlier, theFigure 2: Equilibrium solubilities of acetaminophen in pure SC–CO2 .
Figure 3: Comparison of acetaminophen mole fraction solubility obtained by
Bristow et al. [17], Chang [22] and those obtained in this work at T = 313 (K):
◦, This work;△, Ref. [17]; , Ref. [22].
data were replicated at least three times, and the data reported
in Table 3 are the average of replicas with uncertainties of one
standard deviation. As seen, the solubility of AC in SC–CO2 is in-
creasing as the pressure of the system is increased at a given
temperature. In fact, increasing the pressure can lead to an in-
crease in density and, in turn, the solvating power of SC–CO2.
Also, at a given pressure, the solubility of AC in SC–CO2 is in-
creasing with temperature. Although increasing temperature
can decrease the density of SC–CO2, the reason can be plausi-
bly elucidated by the fact that increasing the temperature can
increase the vapour pressure of pure AC. It should be noted that
the density for SC–CO2 was estimated using the Bender equa-
tion of state [21].
Figure 2 presents the results given in Table 3. The
uncertainties depicted in Table 3 can qualitatively confirm the
repeatability of the experimental data generated in this work.
The comparison of our data to those of Bristow et al. [17] and
those of Chang [22], at the temperature 313 K, is shown in
Figure 3, where the AC solubility is expressed as a function of
pressure.
Tables 4 and 5 present the solubility of AC in SC–CO2 in
the presence of menthol (I) and menthol (II), respectively, at
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P (MPa) T = 313 (K) T = 328 (K) T = 343 (K)
ρ (mol cm−3) 106 · y2 ρ (mol cm−3) 106 · y2 ρ (mol cm−3) 106 · y2
10 0.0143 0.66± 0.04 0.0074 1.04± 0.08 0.0056 2.17± 0.25
15 0.0178 1.01± 0.10 0.0149 1.15± 0.15 0.0115 2.65± 0.3
20 0.0191 1.58± 0.08 0.0172 2.46± 0.05 0.0150 6.70± 0.48
25 0.0200 1.92± 0.03 0.0184 3.06± 0.04 0.0168 9.66± 0.28Table 4: Equilibrium solubilities of acetaminophen (y2) and menthol (I) y3
in SC–CO2 .
T = 313 (K)
P (MPa) ρ (mol cm−3) 103 · y3 106 · y2 E
10 0.0143 4.42± 0.6 2.68± 0.09 4.05
15 0.0178 12.88± 1 4.76± 0.4 4.72
20 0.0191 17.41± 1.19 9.92± 0.8 6.29
25 0.0200 19.94± 1.2 13.37± 1 6.95
T = 328 (K)
10 0.0074 4.67± 0.59 1.44± 0.12 1.38
15 0.0149 6.81± 0.8 1.9± 0.28 1.65
20 0.0172 11.61± 1.2 5.34± 0.5 2.17
25 0.0184 16.71± 1.4 10.68± 0.95 3.49
T = 343 (K)
10 0.0056 7.60± 0.8 4.35± 0.4 2.01
15 0.0115 13.64± 2 5.3± 0.4 2
20 0.0150 21.67± 2.71 13.63± 1.3 2.03
25 0.0168 24.78± 0.43 24.91± 1.93 2.58
Table 5: Equilibrium solubilities of acetaminophen (y2) and menthol (II) y3
in SC–CO2 .
T = 313 (K)
P (MPa) ρ (mol cm−3) 103 · y3 106 · y2 E
10 0.0143 7.21± 0.5 3.90± 0.27 5.91
15 0.0178 12.88± 1.6 7.29± 0.7 7.22
20 0.0191 16.70± 0.32 11.84± 0.6 7.51
25 0.0200 18.47± 0.79 15.91± 1.2 8.27
T = 328 (K)
10 0.0074 3.32± 0.5 2.05± 0.2 1.97
different temperatures and pressures, with uncertainties of
one standard deviation. It can be noticed that the presence
of menthol as a cosolvent can increase the solubility of AC in
SC–CO2. This observation can be justified by change in polarity
of SC–CO2 to dissolve AC in the presence of a polar cosolvent
likementhol. Likewise, as shown in Table 3, the increase in both
pressure and temperature can increase the solubility of AC in
SC–CO2 in the presence of cosolvents.
To better understand the solubility enhancement, a cosol-
vent enhancement effect (E) was defined as the ratio of the
solubility obtained with cosolvent, y2(P, T , y3 ≠ 0), to that
obtained without cosolvent at the same temperature and pres-
sure, y2(P, T , y3 = 0). The enhancement factor is defined by the
following equation:
E = y2(P, T , y3 ≠ 0)
y2(P, T , y3 = 0) . (1)
The calculated values of E were reported in Tables 4 and 5,
from which it could be seen that as pressure increases at
the constant temperature, E will increase. Under the same
operating condition, the enhancement induced by menthol (II)Figure 4: Solubility of acetaminophen in SC–CO2 . The solid line represents the
correlation using Eq. (2) (◦, experimental data).
is greater than that ofmenthol (I). It could be speculated that the
molecular interaction force between menthol-carbon dioxide
and menthol-acetaminophen for two isomers is different;
consequently, the acetaminophen solubility enhancement is
varied.
3.1. Modeling
To model the experimental data for pure acetaminophen in
SC–CO2 the Chrastil [23] and Mendez-Santiago and Teja [24]
models were used. The Chrastil [23] model is written as:
ln y2 = A+ B · ln(ρ)+ CT , (2)
where y2 is the solute’s solubility (mole fraction), ρ is the su-
percritical fluid’s density (mol/cm3), T is the temperature (K)
and A, B and C are three empirical parameters. The physical
meaning of B is the number of solvent molecules associat-
ing with one molecule of solute to form a solvated complex.
The results obtained from the Chrastil [23] model were com-
pared with the experimental data for the solubility of pure AC
in SC–CO2 in Figure 4. Experimental data obtained at all tem-
peratures fit reasonably with Eq. (2), as no systematic devi-
ation between experimental data and the model is observed.
However, the model appears to deviate from experimental
data as CO2 density increases. The solubility data were also
correlated with the semi empirical model of Mendez-Santiago
and Teja [24], which was derived by using a classical expansion
of Helmholtz energy around the critical point of the solvent to
represent the mixture property at infinite dilution. The model
obtained reads:
T · ln(y2.P) = A+ B · yρ + C · T , (3)
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for pure AC in SC–CO2 .
Model A B C 100. AARD
Mendez-Santiago and Teja −9978.95 69661.46 30.83 28.81
Chrastil 26.44 1.261 −6655.2 26.12Figure 5: Solubility of acetaminophen in SC–CO2 . The solid line represents the
correlation using Eq. (3) (◦, experimental data).
where y2 is the solute’s solubility (mole fraction), ρ is the
supercritical fluid’s density (mol/cm3), T is temperature (K), P
is pressure (MPa) and A, B & C are empirical fitting parameters.
The results obtained from the Mendez-Santiago and Teja [24]
model were compared with the experimental data for the
solubility of pure AC in SC–CO2 in Figure 5. As observed, the
model can accurately correlate the data, and no systematic
deviation is observed, even at large CO2 densities. In Table 6,
we report the parameters used to fit Eqs. (2) and (3) to our
experimental data.
The performance of the correlations has been quantified
using an Absolute Average Relative Deviation (AARD). The
AARD is calculated as:
AARDi = 1N
yiexp − yiregyiexp
 , (4)
where yiexp represents experimental data and yireg is calculated
from regression. The results, reported in Table 6, indicate that
the two semi-empiricalmodels correlate our experimental data
with similar AARD.
To model the experimental data for AC in SC–CO2, in
the presence of menthol as cosolvent, we attempted to use
the model developed by Mendez-Santiago and Teja [25] for
the solubility of solids in supercritical CO2 with a cosolvent.
Unfortunately, the model did not yield a satisfactory fit to
our data. Hence, we implemented a further modified version
proposed by Thakur and Gupta [18], which reads:
T · ln(y2 · P) = A+ B · ρ + C .T + (H · ρ + N) · y3. (5)
In Eq. (5), y2 is the solute’s solubility (mole fraction) and y3
is the cosolvent mole fraction. ρ is the supercritical fluid’s
density (mol/cm3), T is temperature (K), P is pressure (MPa)
and the parameters A, B and C are those obtained for pure
AC solubility without cosolvent. The additional parameters H
and N are obtained by fitting Eq. (5) to the experimentalFigure 6: Solubility of acetaminophen in ternary systems, CO2+ ac-
etaminophen + menthol (I). The solid line represents the correlation using
Eq. (5) (◦, experimental data).
Figure 7: Solubility of acetaminophen in ternary systems, CO2 + ac-
etaminophen + menthol (II). The solid line represents the correlation using
Eq. (5) (◦, experimental data).
data. The correlated parameters are presented in Table 7. As
shown in Figures 6 and 7, the correlated AC solubilities in the
presence of menthol (II) as a cosolvent are better than those for
menthol (I).
4. Conclusions
The solubility of acetaminophen in supercritical carbon
dioxide (SC–CO2), with and without menthol as a cosolvent,
was measured at (313, 328 and 343) K, and within pressures
ranging from (10 to 25) MPa. It was found that menthol greatly
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Material A B C H N 100. AARD
Menthol (I) −9978.95 69661.46 30.835 1701.89 −4.755 57
Menthol (II) −20666.58 106683.38 62.94 −4472.484 125.809 23enhanced the solubility of acetaminophen in supercritical
carbon dioxide. Also, the effects of the menthol melting point
on the solubility of acetaminophen in SC–CO2 were studied,
and indicated that menthol (II) yields a higher solubility
enhancement than menthol (I). The data for the solubility of
acetaminophen in SC–CO2, in the presence and in the absence
of menthol (I) andmenthol (II), were correlated using the semi-
empirical equations proposed by Chrastil andMendez-Santiago
& Teja. The results obtained from these equations were in good
agreement with the experimental data in the entire range of
CO2 densities sampled in our experiments.
The solubility results obtained in this work are useful for
the development of RESS-SC processes that could be used to
manufacture acetaminophen based pharmaceuticals.
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